Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammation01:38

Inflammation

57.9K
Overview
57.9K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

412
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
412
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

144
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
144
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

188
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
188
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

196
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
196
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

14.1K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
14.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interleukin-17A mediates cardiorenal injury in oxalate nephropathy.

Cardiovascular research·2026
Same author

LASP1 mediates ADAM17 upregulation in high glucose to promote fibrosis in diabetic kidneys.

Diabetologia·2026
Same author

Molecular determinants of cardiac lymphatic dysfunction in a chronic pressure-overload model.

EMBO molecular medicine·2025
Same author

Allogeneic haematopoietic cell transplantation promotes atherosclerosis in mice via CD8+ T cells.

Cardiovascular research·2025
Same author

Risks to the Unborn: An Umbrella Review on the Effects of Prenatal Maternal Stress Caused by Natural Disasters.

Stress and health : journal of the International Society for the Investigation of Stress·2025
Same author

The self-relevant spotlight metaphor: Self-relevant targets diminish distractor-response-binding effects.

Psychonomic bulletin & review·2024

Related Experiment Video

Updated: Nov 23, 2025

Flow Cytometry Analysis of Immune Cells Within Murine Aortas
15:15

Flow Cytometry Analysis of Immune Cells Within Murine Aortas

Published on: July 1, 2011

35.1K

CD8+ T Cells in Atherosclerosis.

Sarah Schäfer1, Alma Zernecke1

  • 1Institute of Experimental Biomedicine, University Hospital Würzburg, 97080 Würzburg, Germany.

Cells
|January 1, 2021
PubMed
Summary
This summary is machine-generated.

CD8+ T cells play a critical role in atherosclerosis, exhibiting cytotoxic functions that contribute to plaque formation and macrophage death. Modulating these immune cells offers potential new therapeutic strategies for cardiovascular disease.

Keywords:
CD8+ T cellsatherosclerosischeckpoint inhibitorscytotoxic T cellsimmunotherapyinflammationsingle cell RNA sequencing

More Related Videos

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.5K
Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

39.4K

Related Experiment Videos

Last Updated: Nov 23, 2025

Flow Cytometry Analysis of Immune Cells Within Murine Aortas
15:15

Flow Cytometry Analysis of Immune Cells Within Murine Aortas

Published on: July 1, 2011

35.1K
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.5K
Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

39.4K

Area of Science:

  • Immunology
  • Cardiovascular Research
  • Cell Biology

Background:

  • Atherosclerotic lesions contain immune cells, including CD8+ T cells.
  • CD8+ T cells in atherosclerosis display activated, cytotoxic, and potentially exhausted phenotypes.
  • Depletion of CD8+ T cells in mouse models reduces atherosclerosis severity.

Purpose of the Study:

  • To review the multifaceted role of CD8+ T cells in atherosclerosis.
  • To highlight the cytotoxic and regulatory functions of CD8+ T cells in plaque development.
  • To explore the potential of targeting CD8+ T cells for novel atherosclerosis treatments.

Main Methods:

  • Review of existing literature on CD8+ T cell involvement in atherosclerosis.
  • Analysis of cellular phenotypes and functions within atherosclerotic lesions.
  • Examination of experimental data from mouse models and human studies.

Main Results:

  • CD8+ T cells regulate monopoiesis and macrophage accumulation.
  • Cytotoxic CD8+ T cells contribute to necrotic core formation and macrophage death.
  • Regulatory CD8+ T cells can suppress atherosclerotic progression.
  • Antigen-specific CD8+ T cell responses may target plaque components.

Conclusions:

  • CD8+ T cells are key players in atherosclerosis pathogenesis.
  • Their cytotoxic activity can drive plaque instability and endothelial damage.
  • Targeting CD8+ T cell immune checkpoints or subsets presents therapeutic opportunities.